SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (2861)3/22/2020 10:24:15 PM
From: CuttingEdge Bio  Respond to of 3557
 
This is interesting and in stark contrast to the mouse infection study. It would seem that perhaps penetration of drug to the lung is the main hurdle. I wonder how they addressed this or plan to address this with Wuhan.



To: Miljenko Zuanic who wrote (2861)3/26/2020 2:11:49 AM
From: CuttingEdge Bio  Read Replies (1) | Respond to of 3557
 
So are they planning to treat with a nebulizer formulation?
This paper's results are scary to think about.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News